FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1850565512> ?p ?o ?g. }

• W1850565512 abstract "In the last years, circulating matrix metalloproteinases (MMP)-9 levels have been associated with functional outcome in ischemic stroke patients. However the prognostic value of circulating levels of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and MMP-10 in functional outcome of ischemic stroke patients has been scarcely studied. In addition, to our knowledge, serum MMP-9, MMP-10 and TIMP-1 levels in patients with malignant middle cerebral artery infarction (MMCAI) for mortality prediction have not been studied, and these were the objectives of this study. This was a multicenter, observational and prospective study carried out in six Spanish Intensive Care Units. We included patients with severe MMCAI defined as Glasgow Coma Scale (GCS) lower than 9. We measured circulating levels of MMP-9, MMP-10, TIMP-1, in 50 patients with severe MMCAI at diagnosis and in 50 healthy subjects. Endpoint was 30-day mortality. Patients with severe MMCAI showed higher serum levels of MMP-9 (p = 0.001), MMP-10 (p < 0.001), and TIMP-1 (p = 0.02) than healthy subjects. Non-surviving MMCAI patients (n = 26) compared to survivor ones (n = 24) showed higher circulating levels of TIMP-1 (p < 0.001), MMP-10 (p = 0.02) and PAI-1(p = 0.02), and lower MMP-9 levels (p = 0.04). Multiple binomial logistic regression analysis showed that serum TIMP-1 levels > 239 ng/mL are associated with 30-day mortality (OR = 5.82; 95 % CI = 1.37-24.73; P = 0.02) controlling for GCS and age. The area under the curve for TIMP-1 as predictor of 30-day mortality was 0.81 (95 % CI = 0.67-0.91; P < 0.001). We found an association between circulating levels of TIMP-1 and MMP-10 (rho = 0.45; P = 0.001), plasminogen activator inhibitor (PAI)-1 (rho = 0.53; P < 0.001), and tumor necrosis factor (TNF)-alpha (rho = 0.70; P < 0.001). The most relevant and new findings of our study, were that serum TIMP-1 levels in MMCAI patients were associated with mortality, and could be used as a prognostic biomarker of mortality in MMCAI patients." @default.
• W1850565512 created "2016-06-24" @default.
• W1850565512 creator A5015412076 @default.
• W1850565512 creator A5017448314 @default.
• W1850565512 creator A5019935493 @default.
• W1850565512 creator A5026258590 @default.
• W1850565512 creator A5036989703 @default.
• W1850565512 creator A5039203636 @default.
• W1850565512 creator A5047987608 @default.
• W1850565512 creator A5055603009 @default.
• W1850565512 creator A5075324282 @default.
• W1850565512 creator A5083600076 @default.
• W1850565512 creator A5089178181 @default.
• W1850565512 date "2015-07-11" @default.
• W1850565512 modified "2023-10-10" @default.
• W1850565512 title "Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction" @default.
• W1850565512 cites W1485268298 @default.
• W1850565512 cites W1525484196 @default.
• W1850565512 cites W1540258377 @default.
• W1850565512 cites W1545606956 @default.
• W1850565512 cites W1603121691 @default.
• W1850565512 cites W1894541755 @default.
• W1850565512 cites W1964813009 @default.
• W1850565512 cites W1965597112 @default.
• W1850565512 cites W1979226284 @default.
• W1850565512 cites W1979853906 @default.
• W1850565512 cites W1983401409 @default.
• W1850565512 cites W1988769907 @default.
• W1850565512 cites W1991740017 @default.
• W1850565512 cites W2022381785 @default.
• W1850565512 cites W2025373014 @default.
• W1850565512 cites W2032534431 @default.
• W1850565512 cites W2036717742 @default.
• W1850565512 cites W2041849054 @default.
• W1850565512 cites W2052280647 @default.
• W1850565512 cites W2052322755 @default.
• W1850565512 cites W2057816318 @default.
• W1850565512 cites W2059337754 @default.
• W1850565512 cites W2060373263 @default.
• W1850565512 cites W2063614970 @default.
• W1850565512 cites W2066190613 @default.
• W1850565512 cites W2071637551 @default.
• W1850565512 cites W2071651599 @default.
• W1850565512 cites W2072871800 @default.
• W1850565512 cites W2074059782 @default.
• W1850565512 cites W2077839585 @default.
• W1850565512 cites W2083143922 @default.
• W1850565512 cites W2092436449 @default.
• W1850565512 cites W2094943913 @default.
• W1850565512 cites W2096976767 @default.
• W1850565512 cites W2098811327 @default.
• W1850565512 cites W2103114977 @default.
• W1850565512 cites W2124038216 @default.
• W1850565512 cites W2132121238 @default.
• W1850565512 cites W2133833146 @default.
• W1850565512 cites W2151106594 @default.
• W1850565512 cites W2163652382 @default.
• W1850565512 cites W2163952308 @default.
• W1850565512 cites W2409830569 @default.
• W1850565512 cites W2594075545 @default.
• W1850565512 cites W4293242440 @default.
• W1850565512 cites W88536126 @default.
• W1850565512 doi "https://doi.org/10.1186/s12883-015-0364-7" @default.
• W1850565512 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4499187" @default.
• W1850565512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26162891" @default.
• W1850565512 hasPublicationYear "2015" @default.
• W1850565512 type Work @default.
• W1850565512 sameAs 1850565512 @default.
• W1850565512 citedByCount "11" @default.
• W1850565512 countsByYear W18505655122016 @default.
• W1850565512 countsByYear W18505655122018 @default.
• W1850565512 countsByYear W18505655122019 @default.
• W1850565512 countsByYear W18505655122020 @default.
• W1850565512 countsByYear W18505655122021 @default.
• W1850565512 countsByYear W18505655122022 @default.
• W1850565512 crossrefType "journal-article" @default.
• W1850565512 hasAuthorship W1850565512A5015412076 @default.
• W1850565512 hasAuthorship W1850565512A5017448314 @default.
• W1850565512 hasAuthorship W1850565512A5019935493 @default.
• W1850565512 hasAuthorship W1850565512A5026258590 @default.
• W1850565512 hasAuthorship W1850565512A5036989703 @default.
• W1850565512 hasAuthorship W1850565512A5039203636 @default.
• W1850565512 hasAuthorship W1850565512A5047987608 @default.
• W1850565512 hasAuthorship W1850565512A5055603009 @default.
• W1850565512 hasAuthorship W1850565512A5075324282 @default.
• W1850565512 hasAuthorship W1850565512A5083600076 @default.
• W1850565512 hasAuthorship W1850565512A5089178181 @default.
• W1850565512 hasBestOaLocation W18505655121 @default.
• W1850565512 hasConcept C109523444 @default.
• W1850565512 hasConcept C118552586 @default.
• W1850565512 hasConcept C126322002 @default.
• W1850565512 hasConcept C127413603 @default.
• W1850565512 hasConcept C12770488 @default.
• W1850565512 hasConcept C141071460 @default.
• W1850565512 hasConcept C16568411 @default.
• W1850565512 hasConcept C17624336 @default.
• W1850565512 hasConcept C188816634 @default.
• W1850565512 hasConcept C2775841333 @default.
• W1850565512 hasConcept C2777798775 @default.
• W1850565512 hasConcept C2779450755 @default.

• next